1. Home
  2. ARMK vs RDY Comparison

ARMK vs RDY Comparison

Compare ARMK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aramark

ARMK

Aramark

HOLD

Current Price

$37.08

Market Cap

10.1B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.13

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMK
RDY
Founded
1959
1984
Country
United States
India
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
11.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ARMK
RDY
Price
$37.08
$14.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$46.33
$16.90
AVG Volume (30 Days)
3.1M
959.9K
Earning Date
11-17-2025
01-22-2026
Dividend Yield
1.29%
0.51%
EPS Growth
23.23
9.95
EPS
1.22
0.79
Revenue
$18,506,299,000.00
$3,851,623,984.00
Revenue This Year
$8.62
$6.16
Revenue Next Year
$5.86
$2.57
P/E Ratio
$30.38
$17.90
Revenue Growth
6.35
14.10
52 Week Low
$29.92
$12.26
52 Week High
$44.49
$16.17

Technical Indicators

Market Signals
Indicator
ARMK
RDY
Relative Strength Index (RSI) 42.53 55.57
Support Level $36.34 $13.64
Resistance Level $37.51 $14.10
Average True Range (ATR) 0.95 0.18
MACD 0.01 0.04
Stochastic Oscillator 51.61 87.50

Price Performance

Historical Comparison
ARMK
RDY

About ARMK Aramark

Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving various clients including schools, healthcare facilities, and entertainment venues.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: